Results 171 to 180 of about 5,048,722 (239)

Guidance for Home Enzyme Replacement Therapy in Children and Adolescents Diagnosed with Mucopolysaccharidoses: A Scoping Review Protocol. [PDF]

open access: yesInt J Environ Res Public Health
Oliveira VR   +5 more
europepmc   +1 more source

[Case of mucopolysaccharidosis II--Hunter's syndrome].

open access: yesPediatria polska, 1976
M, Walczak   +3 more
openaire   +1 more source

Acute Airway Crisis in Mucopolysaccharidosis VI: Management Challenges. [PDF]

open access: yesDiagnostics (Basel)
Tulebayeva A, Gadepalli C, Sharipova M.
europepmc   +1 more source

Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease)

Current Pharmaceutical Design, 2020
Background:Mucopolysaccharidosis type II (Hunter syndrome, or MPS II) is an X-linked lysosomal disorder caused by the deficiency of iduronate-2-sulfatase, which leads to the accumulation of glycosaminoglycans (GAGs) in a variety of tissues, resulting in a multisystemic disease that can also impair the central nervous system (CNS).Objective:This review ...
Francyne Kubaski   +5 more
openaire   +3 more sources

Nasal Polyposis in mucopolysaccharidosis type II

BMJ Case Reports, 2021
Mucopolysaccharidosis (MPS) type II is a rare multisystem disorder resulting from the accumulation of breakdown products of glycosaminoglycans in the body tissues. Many patients with this disease undergo ENT (ear, nose and throat) surgeries such as adenotonsillectomy and tympanocentesis at a very early age, much before the diagnosis of MPS.
Sushmitha Kabekkodu   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy